Picture of Royalty Pharma logo

RPRX — Royalty Pharma News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Brief: Royalty Pharma Highlights Accomplishments And Provides Business Update

Jan 8 (Reuters) - Royalty Pharma  RPRX.O :
    * HIGHLIGHTS ACCOMPLISHMENTS AND PROVIDES BUSINESS UPDATE AT
42ND
ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
    * SAYS 2023 PORTFOLIO RECEIPTS EXPECTED TO BE APPROXIMATELY
$3,050
MILLION, EXCEEDING UPPER END OF GUIDANCE RANGE
    * ANNOUNCED TRANSACTIONS OF $13 BILLION SINCE 2020 EXPECTED
TO ADD
APPROXIMATELY $1.2 BILLION TO PORTFOLIO RECEIPTS IN 2025

Source text for Eikon:  ID:nGNX1MNxRr 
Further company coverage:  RPRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Royalty Pharma

See all news